ERBB2 and breast carcinoma: Upon treatment of eugenol in human triple-negative MDA-MB 231 breast cancer cells (4 μM and 8 μM) and HER2 positive SK-BR3 (5 μM and 10 μM) breast cancer cells, cell proliferating and migrating ability was inhibited.